Support vector machines classification for discriminating coronary heart disease patients from non-coronary heart disease

West Indian Medical Journal

Volumn 56, Issue 5, 2007, Pages 451-457

  Hongzong, S ^a   Tao, W ^a   Xiaojun, Y ^b   Huanxiang, L ^b   Zhide, H ^b   Mancang, L ^b   BoTao, F ^c  

^a QINGDAO UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHORUS; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CIGARETTE SMOKING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY; FALSE POSITIVE RESULT; FAMILY HISTORY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; VALIDITY;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; CORONARY ARTERY DISEASE; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSIS, DIFFERENTIAL; EQUIPMENT DESIGN; HUMANS; PATTERN RECOGNITION, AUTOMATED; RISK ASSESSMENT; SOFTWARE;

EID: 38949192669     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355: 668-9.
2. Cosín J, Asín E, Marrugat J, Elosua R, Arós F, de los Reyes M et al. Prevalence of angina pectoris in Spain. Euro J Epidemiol 1999; 15: 323-30.
3. Keil U. Prevention der klassischen Risikofaktoren. Drug Res 1990; 40: 1-7.
4. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971; 74: 1-12.
5. Stamler J, Wentworth D. Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823-8.
6. Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A. Systematic under-estimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ 1994; 308: 363-6.
7. Vogel RA. The management of hypercholesterolemia in patients with coronary artery disease: guidelines for primary care. Clin Cornerstone 1998; 1: 51-64.
8. UK Prospective Diabetes Study Group. (UKPDS) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 832-3.
9. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16: 434-44.
10. Kannel W, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-8.
11. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. BMJ 1983; 287: 867-70.
12. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020, Harvard University Press: Cambridge, Mass 1996.
13. Krishnapuram B, Carin L. Proceedings of the seventh annual international conference on Computational molecular biology. Joint classifier and feature optimization for cancer diagnosis using gene expression data, Alexander Hartemink J 2003.
14. Cristianini N, Shawe-Taylor J. An Introduction to Support Vector Machines, Cambridge University Press, 2000.
15. Gunn. "Support vector machines for classification and regression", ISIS technical report, Image Speech & Intelligent Systems Group, University of Southampton, 1997.
16. Boser BE, Guyon IM, Vapnik VN. "A training algorithm for optimal margin classifiers", Proceedings of the 5th Annual ACM Workshop on Computational Learning Theory, ACM Press, 1992 144-152.
17. Liu HX, Zhang RS, Luan F, Yao XJ, Liu MC, Hu ZD, Fan BT. Diagnosing breast cancer Based on support vector machines. J Chem Inf Comput Sci 2003; 43: 900-7.
18. Zhao CY, Zhang RS, Liu HX, Xue CX, Zhao SG, Zhou XF et al. Diagnosing anorexia based on partial least squares, back propagation neural network, and support vector machines. J Chem Inf Comput Sci 2004; 44: 2040-6.
19. Tham CK, Heng CK, Chin WC. Predicting risk of artery disease from DNA microarray-based genotyping neural networks and other statistical analysis tools. J Bioform Comput Biol 2003; 1: 521-39
20. Brown MPS, Grundy WN, Lin D, Cristianini N, Sugnet CW, Furey TS et al. Knowledge-based analysis of microarray gene expression data by using supportvector machines. Proc Natl Acad Sci 2000; 97: 262-7.
21. Ding CH, Dubchak I. Multi-class protein fold recognition using support vector machines and neural networks. Bioinformatics 2001; 17: 349-35.
22. Zien A, Ratsch G., Mika S, Scholkopg B, Lengauer T, Muller KR. Engineering support vector machine kernels that recognize translation initiation sites. Bioinformatics 2000; 16: 799-807.
23. Zavalijevski N, Stevens FJ, Reifman J. Support vector machines with selective kernel scaling for protein classification and identification of key amino acid positions. Bioinformatics 2002; 18: 689-96.
24. Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach Learn 2002; 46: 389-422.
25. Hua S, Su Z. A novel method of protein secondary structure prediction with segment overlap measure, support vector machine approach. J Mol Biol 2001; 308: 397-407.
26. Muller K, Mika S, Ratsch G., Tsuda K, Scholkopf B. An introduction to kernel-based learning algorithms. IEEE Trans 2001; 12: 181-202.
27. Burges CJC. A tutorial on support vector machines for pattern recognition. Data Mining Knowledge Discovery 1998; 2: 121-67.
28. Vapnik V. Estimation of dependencies based on empirical data. Springer, Berlin, 1982.
29. Wang Wi, Xu ZB, Lu WZ, Zhang XY. Determination of the spread parameter in the Gaussian kernel for classification and regression. Neurocomputing 2003; 55: 643-63.
30. Bishop C. Neural networks for pattern recognition, Clarendon Press, Oxford, 1997.
31. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28: 613-28.
32. Laakso M, Lehto S, Pentila I, Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993; 88: 1421-30.
33. Fitzgerald AP, Jarrett RJ. Are conventional risk factors for mortality relevant in type 2 diabetes? Diabet Med 1991; 8: 475-80.
34. Chong PH, Bachenheimer BS. Current, new and future treatments in dyslipidaemia and atherosclerosis. Drugs 2000; 60: 55-93.
35. Betteridge DJ, Morrell JM. Clinician's Guide to Lipids and Coronary Heart Disease. London: Arnold, 1999.
36. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 1986; 256: 2835-8.
37. Abbott RD, Wilson PW, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 1988; 8: 207-11.
38. Donnelly R, Emslie-Smith AM, Gardner ID, Morris AD. ABC of arterial and venous disease: Vascular complications of diabetes. BMJ 2000; 320:1062-6.
39. Frost RJA, Otto C, Geiss HC, Schwandt P, Parhofer KG. Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia. Am J Cardiol 2001; 87: 44-8.
40. Assmann G, Schulte H, Von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996; 77: 1179-84.
41. Assmann G. Pro and con: High-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management. Am J Cardiol 2001; 87: (Suppl) 2B-7B.
42. Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34.
43. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001; 50: 1654-65.